Amgen Inc.
VEGFR-FC FUSION PROTEIN FORMULATIONS

Last updated:

Abstract:

Protein formulations and methods of making and using such formulations are provided herein. The formulation can be an ophthalmic formulation, such as for intravitreal administration. In some embodiments, the formulation comprises a VEGFR-Fc fusion protein, such as aflibercept.

Status:
Application
Type:

Utility

Filling date:

16 Nov 2018

Issue date:

29 Oct 2020